Expression of protein kinase C isoforms and interleukin-1β in myofibrillar myopathy

被引:11
作者
Vattemi, G
Tonin, P
Mora, M
Filosto, M
Morandi, L
Savio, C
Dal Pra, I
Rizzuto, N
Tomelleri, G
机构
[1] Policlin GB Rossi, Neurol Clin, Sect Clin Neurol, Dept Neurol Sci & Vis, I-37134 Verona, Italy
[2] Policlin GB Rossi, Neurol Clin, Histol & Embryol Unit, Verona, Italy
[3] Natl Inst C Besta, Dept Neuromuscular Dis, Milan, Italy
关键词
D O I
10.1212/01.WNL.0000125197.70310.8E
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The term myofibrillar myopathy refers to a rare and clinically heterogeneous group of muscle disorders. The pathogenesis of this myopathy is not well understood. The morphologic hallmark is myofibrillar destruction with abnormal expression of numerous proteins, most consistently of desmin. Methods: The authors investigated eight patients with myofibrillar myopathy belonging to four families. They studied the role of different protein kinase C isoforms and of interleukin-1beta, a cytokine that might activate protein kinase C and, in addition, mediate myofibrillar proteolysis. Results: Immunohistochemical analysis showed the expression of alpha, eta, and zeta isoforms of protein kinase C and of interleukin-1beta in abnormal muscle fibers. Immunoblots confirmed the immunohistochemical data and revealed the absence of protein kinase C delta and epsilon in muscle fibers from patients and controls. Conclusions: These data suggest that protein kinase C and interleukin-1beta may play a role in the pathogenesis of myofibrillar myopathy.
引用
收藏
页码:1778 / 1782
页数:5
相关论文
共 48 条
[1]   HIGHLY SYNCHRONOUS CULTURE OF FIBROBLASTS FROM G2 BLOCK CAUSED BY STAUROSPORINE, A POTENT INHIBITOR OF PROTEIN-KINASES [J].
ABE, K ;
YOSHIDA, M ;
USUI, T ;
HORINOUCHI, S ;
BEPPU, T .
EXPERIMENTAL CELL RESEARCH, 1991, 192 (01) :122-127
[2]   The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis [J].
Amato, AA ;
Kagan-Hallet, K ;
Jackson, CE ;
Lampkin, S ;
Wolfe, GI ;
Ferrante, M ;
Bigio, EH ;
Barohn, RJ .
NEUROLOGY, 1998, 51 (06) :1646-1655
[3]  
Ascer E, 1992, Ann Vasc Surg, V6, P69, DOI 10.1007/BF02000671
[4]  
Authier FJ, 1997, ACTA NEUROPATHOL, V94, P272
[5]   Interleukin-1 expression in inflammatory myopathies: Evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes [J].
Authier, FJ ;
Mhiri, C ;
Chazaud, B ;
Christov, C ;
Cherin, P ;
BarlovatzMeimon, G ;
Gherardi, RK .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (02) :132-140
[6]   STIMULATION OF MUSCLE PROTEIN-DEGRADATION AND PROSTAGLANDIN-E2 RELEASE BY LEUKOCYTIC PYROGEN (INTERLEUKIN-1) - A MECHANISM FOR THE INCREASED DEGRADATION OF MUSCLE PROTEINS DURING FEVER [J].
BARACOS, V ;
RODEMANN, HP ;
DINARELLO, CA ;
GOLDBERG, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) :553-558
[7]   NUCLEAR SUBSTRATES OF PROTEIN-KINASE-C [J].
BECKMANN, R ;
BUCHNER, K ;
JUNGBLUT, PR ;
ECKERSKORN, C ;
WEISE, C ;
HILBERT, R ;
HUCHO, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 210 (01) :45-51
[8]  
Belec L, 1997, J NEUROPATH EXP NEUR, V56, P651
[9]   Differential expressions of protein kinase C isozymes during proliferation and differentiation of human skeletal muscle cells in vitro [J].
Boczán, J ;
Boros, S ;
Mechler, F ;
Kovacs, L ;
Bíró, T .
ACTA NEUROPATHOLOGICA, 2000, 99 (02) :96-104
[10]   INCREASED INTERLEUKIN-1-BETA IN HUMAN SKELETAL-MUSCLE AFTER EXERCISE [J].
CANNON, JG ;
FIELDING, RA ;
FIATARONE, MA ;
ORENCOLE, SF ;
DINARELLO, CA ;
EVANS, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (02) :R451-R455